Innovative research to prevent medication related harm: A University of Queensland research collaboration will look at reducing the risk of harm from medication for inpatients and those leaving hospital to return home. Dr Nazanin Ghahreman-Falconer from UQ’s School of Pharmacy is working with Brisbane’s Princess Alexandra Hospital (PAH) and using digital hospital technologies to better […]
Read More… from Innovative research to prevent medication related harm
An at-home nasal spray treatment for COVID-19 will be put to the test by Melbourne biomedical researchers, as the University of Melbourne and Monash University receive $4.2 million to establish a six-month clinical trial lead by Northern Hospital in collaboration with Oxford University. Heparin, a widely used blood-thinning drug to treat or prevent blood clots […]
Read More… from COVID-19 nasal spray heads to clinical trial
Anticoagulant has beneficial side-effects for COVID-19 patients: Clotting problems and resulting complications are common in COVID-19 patients. Researchers at the Medical University of Vienna have now shown that a member of the anticoagulant group of drugs not only has a beneficial effect on survival of COVID-19 patients, but also influences the duration of active infection […]
Read More… from Anticoagulant has benefits for COVID-19 patients